Linezolid versus vancomycin for skin and soft tissue infections.

ABSTRACT:

Background

The morbidity and treatment costs associated with skin and soft tissue infections (SSTIs) are high. Linezolid and vancomycin are antibiotics that are commonly used in treating skin and soft-tissue infections, specifically those infections due to methicillin-resistant Staphylococcus aureus (MRSA).

Objectives

To compare the effects and safety of linezolid and vancomycin for treating people with SSTIs.

Search methods

For this first update of this review we conducted searches of the following databases: Cochrane Wounds Group Specialised Register (searched 24 March 2015; The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library); Ovid MEDLINE; Ovid MEDLINE (In-Process & Other Non-Indexed Citations); Ovid EMBASE; and EBSCO CINAHL. We also

SUBMITTER: Yue J 

PROVIDER: S-EPMC10435313 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature